You just read:

Vividion Therapeutics to Present Data on Novel Covalent E3 Ligase Engager Supporting Broad Targeted Protein Degradation at 2020 AACR Annual Meeting

News provided by

Vividion Therapeutics

May 15, 2020, 08:00 ET